跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
509
首页
药物
509
509
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent
US 10668077 B2
申请人: KARUS THERAPEUTICS LTD
优先权: 2015
CN
EP
US
WO
10 件公开
Immunogenic compositions for streptococcus pyogenes
US 7709009 B2
申请人: NOVARTIS VACCINES & DIAGNOSTIC
优先权: 2004
US
8 件公开
Stable phi29 DNA polymerase having high enzyme activity, and encoding gene and application thereof
US 12655399 B2
申请人: BGI SHENZHEN
优先权: 2020
CN
EP
US
WO
5 件公开
STABILIZED TRIMERIC RSV FUSION PROTEINS WITHOUT A HETEROLOGOUS TRIMERZATION DOMAIN
US 20260207729 A1
申请人: MSD INT BUSINESS GMBH
优先权: 2023
CN
EP
US
WO
4 件公开
ANTICANCER COMPOSITIONS
EP 4494636 A3
申请人: ARAGON PHARMACEUTICALS INC
优先权: 2014
CN
EP
US
4 件公开
US 10285948 B2
申请人: ARAGON PHARMACEUTICALS INC
优先权: 2014
CN
US
4 件公开
CN 106999430 A
申请人: ARAGON PHARMACEUTICALS INC
优先权: 2014
CN
2 件公开
CN 109219437 A
申请人: ARAGON PHARMACEUTICALS INC
优先权: 2016
CN
Nucleic acid encoding human tango 509
US 7041474 B2
申请人: MILLENNIUM PHARM INC
优先权: 2001
US
4 件公开
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
US 2008213778 A1
申请人: MILLENNIUM PHARM INC
优先权: 2007
US
3 件公开
US 2012270219 A1
申请人: HOLTZMAN DOUGLAS A
优先权: 2012
US
2 件公开
Crystalline forms of ARN-509, preparation method and use thereof
US 11066384 B2
申请人: CRYSTAL PHARMACEUTICAL SUZHOU CO LTD
优先权: 2018
CN
US
2 件公开
THE CRL5SPSB3 UBIQUITIN LIGASE TARGETS NUCLEAR CGAS FOR DEGRADATION
EP 4731756 A1
申请人: ECOLE POLYTECHNIQUE FED LAUSANNE EPFL
优先权: 2023
EP
WO
2 件公开
Method for the treatment of diseases requiring inhibition or a reduction in the activity of pH value-regulating bicarbonate transporter proteins
US 7309706 B2
申请人: SOLVAY PHARM GMBH
优先权: 2002
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈